134 related articles for article (PubMed ID: 8148465)
1. Platelet-activating factor biosynthesis in rat vascular smooth muscle cells.
Tomlinson PR; Croft K; Harris T; Stewart AG
J Vasc Res; 1994; 31(3):144-52. PubMed ID: 8148465
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of BQ-123 on endothelin-1-stimulated mitogen-activated protein kinase and cell growth of rat vascular smooth muscle cells.
Guo X; Okada K; Fujita N; Ishikawa S; Komatsu N; Saito T
Hypertens Res; 1996 Mar; 19(1):23-30. PubMed ID: 8829820
[TBL] [Abstract][Full Text] [Related]
3. Carvedilol inhibits vascular smooth muscle cell proliferation.
Sung CP; Arleth AJ; Ohlstein EH
J Cardiovasc Pharmacol; 1993 Feb; 21(2):221-7. PubMed ID: 7679155
[TBL] [Abstract][Full Text] [Related]
4. Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor.
Filep JG; Sirois MG; Rousseau A; Fournier A; Sirois P
Br J Pharmacol; 1991 Dec; 104(4):797-804. PubMed ID: 1667286
[TBL] [Abstract][Full Text] [Related]
5. Effect of platelet-activating factor (PAF) receptor blockers on smooth muscle cell replication in vitro and allograft arteriosclerosis in vivo.
Räisänen A; Mennander A; Ustinov J; Paavonen T; Häyry P
Transpl Int; 1993; 6(5):251-7. PubMed ID: 8216700
[TBL] [Abstract][Full Text] [Related]
6. Paf antagonists block induction of nitric oxide synthase in cultured macrophages and vascular smooth muscle cells.
Arthur JF; Shahin S; Dusting GJ
Clin Exp Pharmacol Physiol; 1995; 22(6-7):452-4. PubMed ID: 8582100
[TBL] [Abstract][Full Text] [Related]
7. Platelet-activating factor (PAF) receptor-mediated calcium mobilization and phosphoinositide turnover in neurohybrid NG108-15 cells: studies with BN50739, a new PAF antagonist.
Yue TL; Gleason MM; Gu JL; Lysko PG; Hallenbeck J; Feuerstein G
J Pharmacol Exp Ther; 1991 Apr; 257(1):374-81. PubMed ID: 1850473
[TBL] [Abstract][Full Text] [Related]
8. Interaction of platelet-activating factor with endothelial and vascular smooth muscle cells in coculture.
Stoll LL; Spector AA
J Cell Physiol; 1989 May; 139(2):253-61. PubMed ID: 2715186
[TBL] [Abstract][Full Text] [Related]
9. [Lung 3H-thymidine incorporation in monocrotaline (MCT)-treated rats--role of platelet-activating factor (PAF)].
Ono S; Tanita T; Ashino Y; Noda M; Tabata S; Hoshikawa Y; Ueda S; Nishimura T; Fujimura S
Nihon Kyobu Shikkan Gakkai Zasshi; 1994 May; 32(5):441-5. PubMed ID: 8084100
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the contractile and calcium-increasing properties of platelet-activating factor and endothelin-1 in the rat mesenteric artery and vein.
Claing A; Shbaklo H; Plante M; Bkaily G; D'Orléans-Juste P
Br J Pharmacol; 2002 Jan; 135(2):433-43. PubMed ID: 11815379
[TBL] [Abstract][Full Text] [Related]
11. The effect of lovastatin on proliferation of cultured rat mesangial and aortic smooth muscle cells.
Choi KH; Kang SW; Lee SW; Lee HY; Han DS; Kang BS
Yonsei Med J; 1995 Jul; 36(3):251-61. PubMed ID: 7660676
[TBL] [Abstract][Full Text] [Related]
12. A role for platelet-activating factor in endothelin-1-induced rat mesangial cell proliferation.
Montero A; Rodriguez-Barbero A; López-Novoa JM
Eur J Pharmacol; 1993 Oct; 243(3):235-40. PubMed ID: 8276075
[TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor-induced homologous and heterologous desensitization in cultured vascular smooth muscle cells.
Schwertschlag US; Whorton AR
J Biol Chem; 1988 Sep; 263(27):13791-6. PubMed ID: 3262105
[TBL] [Abstract][Full Text] [Related]
14. Platelet-activating factor and WEB-2086 directly modulate rat cardiomyocyte contractility.
Delbridge LM; Stewart AG; Goulter CM; Morgan TO; Harris PJ
J Mol Cell Cardiol; 1994 Feb; 26(2):185-93. PubMed ID: 8006979
[TBL] [Abstract][Full Text] [Related]
15. Endothelin-induced mobilization of Ca2+ and the possible involvement of platelet activating factor and thromboxane A2.
Takayasu M; Kondo K; Terao S
Biochem Biophys Res Commun; 1989 Apr; 160(2):751-7. PubMed ID: 2655596
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary vascular reactivity: effect of PAF and PAF antagonists.
Chen CR; Voelkel NF; Chang SW
J Appl Physiol (1985); 1992 Nov; 73(5):1762-9. PubMed ID: 1474049
[TBL] [Abstract][Full Text] [Related]
17. Endothelin-1 and platelet activating factor stimulate thromboxane A2 biosynthesis in rat vascular smooth muscle cells.
Takayasu-Okishio M; Terashita Z; Kondo K
Biochem Pharmacol; 1990 Dec; 40(12):2713-7. PubMed ID: 2260994
[TBL] [Abstract][Full Text] [Related]
18. Induction of endothelin secretion by angiotensin II: effects on growth and synthetic activity of vascular smooth muscle cells.
Scott-Burden T; Resink TJ; Hahn AW; Vanhoutte PM
J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S96-100. PubMed ID: 1725442
[TBL] [Abstract][Full Text] [Related]
19. Mesenteric vascular smooth muscle cells from spontaneously hypertensive rats display increased calcium responses to angiotensin II but not to endothelin-1.
Touyz RM; Tolloczko B; Schiffrin EL
J Hypertens; 1994 Jun; 12(6):663-73. PubMed ID: 7963491
[TBL] [Abstract][Full Text] [Related]
20. Platelet-activating factor mediates CD40-dependent angiogenesis and endothelial-smooth muscle cell interaction.
Russo S; Bussolati B; Deambrosis I; Mariano F; Camussi G
J Immunol; 2003 Nov; 171(10):5489-97. PubMed ID: 14607955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
